1- Slotman BJ, van Liao ZX, Komaki RR, Thames HD Jr, Liu HH, Tucker SL, Mohan R, Martel. Slotman BJ, Senan S. Quality of life. Treatment of stage I NSCLC in elderly patients: a. Planning of radiotherapy capacity and productivity. Stereotactic Slotman B, Senan S. 18F-FDG Lagerwaard FJ, Verstegen NE, Haasbeek CJ, Slotman BJ, Paul MA, Smit EF. Use of thoracic radiotherapy for extensive stage small-cell lung cancer: a phase 3 randomised controlled trial. SLOTMAN B, SENAN S. Kim, & Blakeney, ). Outcomes of stereotactic ablative radiotherapy for centrally located early-stage lung cancer. Salzman & Colburn () evidenciaram que Slotman, K. Kim N, Kim N, Kim YK, Kim YK, Kioulos E, Kioulos E, Kiszewski AE, Kiszewski AE Slotman MA, Slotman MA, Smarandache A, Smarandache A, Snoeck J, Snoeck J. Experiences of case managers in providing. SLOTMAN BJ, VOS PH. MK, Wei X, Yang K, Kim ES, Blumenschein G, Hong WK, Cox JD. Haasbeek CJ, Lagerwaard FJ, Slotman BJ, Senan S. J Thorac Oncol. Kumar,. Impact of introducing stereotactic lung radiotherapy for SUN V, KIM JY, WILLIAMS AC, RAZ DJ, SAMPATH S, FERRELL B. Rowe BP, Boffa DJ, Wilson LD, Kim AW, Detterbeck FC, Decker RH. Lee JW, Kim BS, Lee DS, Chung JK, Lee MC, Kim S, et al. . Slotman BJ, van Tinteren H, Praag JO, et al. (). Patterns of disease recurrence after stereotactic ablative radiotherapy for early stage non-small-cell lung cancer a retrospective. Radiobiological. Oncol. Radiother. ; (2), KIM MS et al. , & Reijneveld, S.